STEM Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.

Press releases published on July 9, 2026

Der Bericht „State of Corporate Purpose 2026“ von Benevity zeigt: Unternehmensspenden steigen trotz soziopolitischem Druck um acht Punkte
Le rapport de Benevity sur l’engagement sociétal des entreprises de 2026 révèle une hausse de huit points des dons d’entreprise dans un contexte de pressions sociopolitiques accrues
Cineplex Reports Impressive June Results with 11% Q2 Box Office Growth and Record Q2 Concession Revenue
SalesHood Expands Agentic Revenue Enablement Platform with Native Support for 19 Languages
L’Agence des médicaments du Canada émet une recommandation favorable au remboursement d’EMPAVELI (pegcétacoplan) dans le traitement de la C3G et de la IC-MPGN primaire
Canada’s Drug Agency Issues Positive Reimbursement Recommendation for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
Oh!mino Survey Finds GLP-1 Muscle Loss Concerns Drive New Focus on Preserving Muscle While Dieting
Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants
Inventiva annonce la finalisation de la restructuration des BSA BEI à la suite de l'émission des Nouveaux BSA BEI
Crane NXT Announces Dates for Second Quarter 2026 Earnings Release and Earnings Call
AppFolio, Inc. Announces Date of Second Quarter 2026 Financial Results Conference Call
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026
Varonis Announces Date of Second Quarter 2026 Financial Results
Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates
Amneal to Report Second Quarter 2026 Results on July 30, 2026
SiTime Corporation to Announce Second Quarter 2026 Financial Results on August 5, 2026
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

STEM Minnesota

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.